| Mr Russell R Fast, LICSW | |
|
1679 6th Ave W, Dickinson, ND 58601-2904 | |
| (701) 483-1000 | |
| (701) 483-1001 |
| Full Name | Mr Russell R Fast |
|---|---|
| Gender | Male |
| Speciality | Clinical Social Worker |
| Experience | 32 Years |
| Location | 1679 6th Ave W, Dickinson, North Dakota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578593026 | NPI | - | NPPES |
| 1455118 | Medicaid | ND | |
| 12990 | Other | ND | BC/BS PIN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 2212 (North Dakota) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Therapy Solutions Llc | 0648455949 | 18 |
News Archive
Aripiprazole is currently approved to treat bipolar disorder as well as schizophrenia. A new study has found that it significantly and dose-dependently increases the sedative effects of alcohol and, to a lesser degree, decreases the euphoric effects of alcohol. Future research will need to examine the beneficial versus the side effects of aripiprazole for treatment of alcohol dependence.
The U.N. General Assembly will move to formally adopt a new "gender entity" on Friday called "U.N. Women" that will fold the U.N.'s four existing women's entities - UNIFEM, the Office of the Special Adviser on Gender Issues, the U.N. Division for the Advancement of Women and INSTRAW - into one, Inter Press Service reports.
Scientists at the University of California, Berkeley, have engineered a new way to deliver CRISPR-Cas9 gene-editing technology inside cells and have demonstrated in mice that the technology can repair the mutation that causes Duchenne muscular dystrophy, a severe muscle-wasting disease.
In Virginia, The Washington Post traces the behind-the-scenes deal-making to create a job for the Democrat state lawmaker whose resignation gave Republicans control of the chamber and the ability to block Gov. Terry McAuliffe's plan to expand Medicaid. Meanwhile, a Missouri hospital lays off 60 employees, blaming the state's failure to expand Medicaid.
Repros Therapeutics Inc. today announced it has commenced preparation for dosing the 3 mg cohort in the Company's low dose study of Proellex® following a safety review of data from women that have completed 8 weeks of treatment at a 1 mg dose. No signals of liver toxicity were detected to date in the 1 mg group. Unexpectedly, low levels of drug activity were detected in this first cohort. The Company plans to commence dosing of the second group, 3 mg Proellex, next week.
› Verified 9 days ago
| Entity Name | Therapy Solutions Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801195045 PECOS PAC ID: 0648455949 Enrollment ID: O20110502000567 |
News Archive
Aripiprazole is currently approved to treat bipolar disorder as well as schizophrenia. A new study has found that it significantly and dose-dependently increases the sedative effects of alcohol and, to a lesser degree, decreases the euphoric effects of alcohol. Future research will need to examine the beneficial versus the side effects of aripiprazole for treatment of alcohol dependence.
The U.N. General Assembly will move to formally adopt a new "gender entity" on Friday called "U.N. Women" that will fold the U.N.'s four existing women's entities - UNIFEM, the Office of the Special Adviser on Gender Issues, the U.N. Division for the Advancement of Women and INSTRAW - into one, Inter Press Service reports.
Scientists at the University of California, Berkeley, have engineered a new way to deliver CRISPR-Cas9 gene-editing technology inside cells and have demonstrated in mice that the technology can repair the mutation that causes Duchenne muscular dystrophy, a severe muscle-wasting disease.
In Virginia, The Washington Post traces the behind-the-scenes deal-making to create a job for the Democrat state lawmaker whose resignation gave Republicans control of the chamber and the ability to block Gov. Terry McAuliffe's plan to expand Medicaid. Meanwhile, a Missouri hospital lays off 60 employees, blaming the state's failure to expand Medicaid.
Repros Therapeutics Inc. today announced it has commenced preparation for dosing the 3 mg cohort in the Company's low dose study of Proellex® following a safety review of data from women that have completed 8 weeks of treatment at a 1 mg dose. No signals of liver toxicity were detected to date in the 1 mg group. Unexpectedly, low levels of drug activity were detected in this first cohort. The Company plans to commence dosing of the second group, 3 mg Proellex, next week.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Russell R Fast, LICSW 1679 6th Ave W, Dickinson, ND 58601-2904 Ph: (701) 483-1000 | Mr Russell R Fast, LICSW 1679 6th Ave W, Dickinson, ND 58601-2904 Ph: (701) 483-1000 |
News Archive
Aripiprazole is currently approved to treat bipolar disorder as well as schizophrenia. A new study has found that it significantly and dose-dependently increases the sedative effects of alcohol and, to a lesser degree, decreases the euphoric effects of alcohol. Future research will need to examine the beneficial versus the side effects of aripiprazole for treatment of alcohol dependence.
The U.N. General Assembly will move to formally adopt a new "gender entity" on Friday called "U.N. Women" that will fold the U.N.'s four existing women's entities - UNIFEM, the Office of the Special Adviser on Gender Issues, the U.N. Division for the Advancement of Women and INSTRAW - into one, Inter Press Service reports.
Scientists at the University of California, Berkeley, have engineered a new way to deliver CRISPR-Cas9 gene-editing technology inside cells and have demonstrated in mice that the technology can repair the mutation that causes Duchenne muscular dystrophy, a severe muscle-wasting disease.
In Virginia, The Washington Post traces the behind-the-scenes deal-making to create a job for the Democrat state lawmaker whose resignation gave Republicans control of the chamber and the ability to block Gov. Terry McAuliffe's plan to expand Medicaid. Meanwhile, a Missouri hospital lays off 60 employees, blaming the state's failure to expand Medicaid.
Repros Therapeutics Inc. today announced it has commenced preparation for dosing the 3 mg cohort in the Company's low dose study of Proellex® following a safety review of data from women that have completed 8 weeks of treatment at a 1 mg dose. No signals of liver toxicity were detected to date in the 1 mg group. Unexpectedly, low levels of drug activity were detected in this first cohort. The Company plans to commence dosing of the second group, 3 mg Proellex, next week.
› Verified 9 days ago
Mrs. Brenda Jo Erie, LICSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 448 21st St W Ste D1, Therapy Solutions, Dickinson, ND 58601 Phone: 701-483-1000 Fax: 701-483-1001 | |
Regina Marie Murray, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 11 2nd Ave E, Ste. B, Dickinson, ND 58601 Phone: 701-483-9720 | |
Channing Spradling, PCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1463 I94 Business Loop E, Dickinson, ND 58601 Phone: 701-227-7500 | |
Ms. Linda Kathryn Waller, LICSW, BCD, DCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 300 13th Ave W Ste 1, Dickinson, ND 58601 Phone: 701-227-7508 Fax: 701-227-7575 | |
Dawn Stewart, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 300 13th Ave W Ste 1, Dickinson, ND 58601 Phone: 701-227-7500 Fax: 701-227-7575 | |
Gerald Mathias Dassinger, LICSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 11 2nd Ave E, Suite B, Dickinson, ND 58601 Phone: 701-483-9720 |